Takahiro Kuno: Management of VTE Across Renal Function and Hemodialysis Status
Takahiro Kuno, Visiting Researcher at The University of Tokyo Hospital, Cardiologist and PhD Candidate at Gunma University Hospital, shared a post on LinkedIn:
“A bit delayed, but I had the privilege of attending ACC.26 in New Orleans last month.
I presented our analysis from the COMMAND VTE Registry-2 examining management and outcomes of venous thromboembolism (VTE) across renal function and hemodialysis status.
A key takeaway: bleeding risk in VTE patients is not driven by eGFR alone—being on hemodialysis itself confers additional bleeding risk, beyond what renal function metrics capture.
This nuance matters when we counsel patients on anticoagulation strategy.
It was also my first time in New Orleans, and the jazz culture was a wonderful surprise.
I’d love to go back.
Grateful to all collaborators in the COMMAND VTE Registry-2 investigators group, and to my mentors for their guidance.”
Stay updated with Hemostasis Today.
-
Sep 28, 2026, 03:59Rahul Saha: JAMA The 49th Human Blood Group System
-
Sep 28, 2026, 01:51Ann Mullally: Expect to See Lots More Gene Therapy in Medicine in the Years Ahead
-
Sep 27, 2026, 15:49Rana Al-Hrout: Iron Deficency – Is Ferritin 15ng/mL or Less Still the Cutoff?
-
Sep 27, 2026, 15:49Ayushi Sharma: What I Thought Transfusion Medicine Would Be vs What It Actually Is
-
Sep 27, 2026, 15:48William Wallace: How Much Human Research Is Behind the Supplements We Take?
-
Sep 27, 2026, 15:46Franck Perraudin: Lp(a) Lowering Alone May Not Be Enough
-
Sep 27, 2026, 15:41Ahmed Hamandi: Sharing Real-World HSCT Experience at the Iraqi Society of Haematology Conference
-
Sep 27, 2026, 15:39Co-creating Digital Support With Young Stroke Survivors – European Stroke Organisation
-
Sep 27, 2026, 15:39Eleri Schiavone: Celebrating 80 Years of the Welsh Blood Service